Skip to content

news

TaBriX receives award from the ERDF

TaBriX has received an award from the European Regional Development Fund Research and Innovation Health Accelerator Programme.

TaBriX awarded by UoM Innovation Factory

TaBriX has recently received a Proof-of-Principle award from the University of Manchester Innovation Factory to support the completion of the lead optimisation programme of TaBriX assets.

TaBriX awarded by incate

TaBriX has received an award for €10,000 from INCATE, an Incubator for AntibacterialTherapies in Europe that supports innovation to fight drug-resistant bacterial infections.

TaBriX and UoM working with TB Alliance to develop novel drugs to treat drug-resistant tuberculosis

TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections.  TaBriX’s initial focus is on the treatment of drug-resistant TB. The team has developed a series… Read More »TaBriX and UoM working with TB Alliance to develop novel drugs to treat drug-resistant tuberculosis